FindTrial
Sign In

Safety and efficacy of non-anesthesiologist administrated propofol during endoscopic submucosal dissection of gastric epithelial tumors in patient with co-morbidity on American society of anaesthesiologists physical status classification

Safety and efficacy of non-anesthesiologist administrated propofol during endoscopic submucosal dissection of gastric epithelial tumors in patient with co-morbidity on American society of anaesthesiologists physical status classification - A study on the safety and efficacy of propofol sedation

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000033877
Enrollment
500
Registered
2018-08-24
Start date
2011-04-02
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric epithelial tumors

Interventions

None listed

Sponsors

Dokkyo medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: All cases due to undergo gastric ESD was included in this study.

Exclusion criteria

Exclusion criteria: patient with allergy to soybeans

Design outcomes

Primary

MeasureTime frame
the safety of sedation by non-anesthesiologist administrated propofol in patient with comorbidity during ESD—

Secondary

MeasureTime frame
Adverse events related to ESD, Clinicopathological tumor characteristics, and Hospital stay—

Countries

Japan

Contacts

Public ContactKeiichiro Abe

Dokkyo medical University Department of Gastroenterology

abebe0319@gmail.com0282861111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026